Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Minna Lehto"'
Autor:
Kimmo Porkka, Olli Kallioniemi, Caroline A. Heckman, Krister Wennerberg, Tero Aittokallio, Satu Mustjoki, Bjorn Tore Gjertsen, Maija Wolf, Minna Lehto, Riikka Räty, Janna Saarela, Katja Kivinen, Imre Västrik, Alun Parsons, Laura Turunen, Jani Saarela, Swapnil Potdar, Samuli Eldfors, Matti Kankainen, Olli Dufva, Heikki Kuusanmäki, Monica Hellesøy, Bhagwan Yadav, Mika Kontro, Oscar Brück, Ashwini Kumar, Disha Malani
We generated ex vivo drug-response and multiomics profiling data for a prospective series of 252 samples from 186 patients with acute myeloid leukemia (AML). A functional precision medicine tumor board (FPMTB) integrated clinical, molecular, and func
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::336d0fdf55697653756deb0b188488b8
https://doi.org/10.1158/2159-8290.c.6549394.v1
https://doi.org/10.1158/2159-8290.c.6549394.v1
Autor:
Kimmo Porkka, Olli Kallioniemi, Caroline A. Heckman, Krister Wennerberg, Tero Aittokallio, Satu Mustjoki, Bjorn Tore Gjertsen, Maija Wolf, Minna Lehto, Riikka Räty, Janna Saarela, Katja Kivinen, Imre Västrik, Alun Parsons, Laura Turunen, Jani Saarela, Swapnil Potdar, Samuli Eldfors, Matti Kankainen, Olli Dufva, Heikki Kuusanmäki, Monica Hellesøy, Bhagwan Yadav, Mika Kontro, Oscar Brück, Ashwini Kumar, Disha Malani
11 supplement tables
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9eee1ceb6573c8b675d4545fab95310
https://doi.org/10.1158/2159-8290.22540483
https://doi.org/10.1158/2159-8290.22540483
Autor:
Kimmo Porkka, Olli Kallioniemi, Caroline A. Heckman, Krister Wennerberg, Tero Aittokallio, Satu Mustjoki, Bjorn Tore Gjertsen, Maija Wolf, Minna Lehto, Riikka Räty, Janna Saarela, Katja Kivinen, Imre Västrik, Alun Parsons, Laura Turunen, Jani Saarela, Swapnil Potdar, Samuli Eldfors, Matti Kankainen, Olli Dufva, Heikki Kuusanmäki, Monica Hellesøy, Bhagwan Yadav, Mika Kontro, Oscar Brück, Ashwini Kumar, Disha Malani
Supplement text file including supplement figures, supplementary table legends and supplement methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e45984f0e236d484392c15d0883c07ae
https://doi.org/10.1158/2159-8290.22540489
https://doi.org/10.1158/2159-8290.22540489
Autor:
Satu Mustjoki, Heikki Kuusanmäki, Mika Kontro, Riikka Räty, Olli Kallioniemi, Swapnil Potdar, Bhagwan Yadav, Ashwini Kumar, Imre Vastrik, Disha Malani, Janna Saarela, Bjørn Tore Gjertsen, Monica Hellesøy, Matti Kankainen, Minna Lehto, Krister Wennerberg, Katja Kivinen, Samuli Eldfors, Maija Wolf, Alun Parsons, Kimmo Porkka, Olli Dufva, Tero Aittokallio, Caroline A. Heckman, Laura Turunen, Oscar Brück, Jani Saarela
Publikováno v:
Malani, D, Kumar, A, Brück, O, Kontro, M, Yadav, B, Hellesøy, M, Kuusanmäki, H, Dufva, O, Kankainen, M, Eldfors, S, Potdar, S, Saarela, J, Turunen, L, Parsons, A, Västrik, I, Kivinen, K, Saarela, J, Räty, R, Lehto, M, Wolf, M, Gjertsen, B T, Mustjoki, S, Aittokallio, T, Wennerberg, K, Heckman, C A, Kallioniemi, O & Porkka, K 2022, ' Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia ', Cancer Discovery, vol. 12, no. 2, pp. 388-401 . https://doi.org/10.1158/2159-8290.CD-21-0410
Cancer Discovery
Cancer Discovery
We generated ex vivo drug-response and multiomics profiling data for a prospective series of 252 samples from 186 patients with acute myeloid leukemia (AML). A functional precision medicine tumor board (FPMTB) integrated clinical, molecular, and func
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93063fdfc5aabf89afd8852a8d1aa88b
http://hdl.handle.net/10852/92100
http://hdl.handle.net/10852/92100
Civil Inattention in Public Places: Normalising Unusual Events through Mobile and Embodied Practices
Autor:
Pentti Haddington, Sami Frogell, Anna Grubert, Heidi Huhta, Pauli Jussila, Juha Kinnunen, Antti Korpela, Minna Lehto, Anna Marin, Juho Mäenpää, Lasse Mäkivuoti, Henna Raappana, Joonas Råman, Jaakko Saarela, Annariina Seppänen, Ilkka Suhonen, Johanna Vanhatapio, Lasse Vesisenaho
Publikováno v:
Forum: Qualitative Social Research, Vol 13, Iss 3 (2012)
This article builds on GOFFMAN's work to study how pedestrians display their orientation to unusual events in public places. It focuses on the mobile and embodied conduct of those passing a smartmob event in which a performing group "froze" in a busy
Externí odkaz:
https://doaj.org/article/217c686fd8c34aeabbb4bc2ae5199654
Autor:
Johanna Rimpiläinen, Merja Suominen, Eira Poikonen, Maija Mikkola, Auvo Rauhala, Riikka Räty, Erkki Elonen, Tuomo Honkanen, Outi Kuittinen, Mirja Vapaatalo, Sirkku Jyrkkiö, Marja-Liisa Karjalainen-Lindsberg, Anu Räsänen, Esa Jantunen, Sanna Siitonen, Minna Lehto
Publikováno v:
Leukemia & Lymphoma. 53:1920-1928
There is no consensus on treatment strategies for elderly patients with mantle cell lymphoma (MCL). In this prospective phase II study we investigated whether the poor outcome could be improved, with reasonable toxicity, by prolonging the immunochemo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e24a1ba8b00a06377fd484c12275a012
https://doi.org/10.3109/10428194.2012.672736
https://doi.org/10.3109/10428194.2012.672736
Autor:
Minna Lehto, Marja-Liisa Karjalainen-Lindsberg, Tuomo Honkanen, Eira Poikonen, Erkki Elonen, Merja Suominen, Esa Jantunen, Maija Mikkola, Johanna Rimpiläinen, Riikka Räty, Sanna Siitonen, Outi Kuittinen, Sirkku Jyrkkiö, Anu Räsänen, Mirja Vapaatalo, Auvo Rauhala
Publikováno v:
Blood. 124:1749-1749
Background Rituximab (R) maintenance therapy bimonthly until progression has been shown in a recent randomized study to prolong duration of remission (with median follow-up of 37 months) and overall survival in elderly patients (pts) with MCL after R
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::da6b91e391ecef50e319605793da2e87
https://doi.org/10.1182/blood.v124.21.1749.1749
https://doi.org/10.1182/blood.v124.21.1749.1749
Autor:
Esa Jantunen, Eira Poikonen, Auvo Rauhala, Johanna Rimpiläinen, Erkki Elonen, Riikka Räty, Tuomo Honkanen, Sanna Siitonen, Merja Suominen, Marja-Liisa Karjalainen-Lindsberg, Mirja Vapaatalo, Sirkku Jyrkkiö, Outi Kuittinen, Minna Lehto, Anu Räsänen
Publikováno v:
Blood. 112:1001-1001
Background: The Nordic Lymphoma Group has shown that adding cytarabine (AraC) and rituximab (R) to high dose CHOP and autologous stem cell transplantation increases response rate, event free survival (EFS), progression free survival (PFS) and overall
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9512f1c6bab6908a274b211fa4d9a243
https://doi.org/10.1182/blood.v112.11.1001.1001
https://doi.org/10.1182/blood.v112.11.1001.1001
Autor:
Frick, Andrea1 (AUTHOR) andrea.frick@unifr.ch, Pichelmann, Stefan1 (AUTHOR)
Publikováno v:
Journal of Intelligence. Aug2023, Vol. 11 Issue 8, p165. 19p.
Autor:
Józsa, Krisztián1,2 (AUTHOR) jozsa@sol.cc.u-szeged.hu, Amukune, Stephen3,4 (AUTHOR), Zentai, Gabriella2 (AUTHOR), Barrett, Karen Caplovitz5 (AUTHOR)
Publikováno v:
Journal of Intelligence. Sep2022, Vol. 10 Issue 3, pN.PAG-N.PAG. 19p.